ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10 | -23.1% | 282 | 0.0% | 0.00% | – |
Q2 2023 | $13 | +18.2% | 282 | 0.0% | 0.00% | – |
Q1 2023 | $11 | -15.4% | 282 | 0.0% | 0.00% | – |
Q4 2022 | $13 | -99.9% | 282 | +8.0% | 0.00% | – |
Q3 2022 | $11,000 | -31.2% | 261 | 0.0% | 0.00% | – |
Q2 2022 | $16,000 | +14.3% | 261 | +31.2% | 0.00% | – |
Q1 2022 | $14,000 | -17.6% | 199 | 0.0% | 0.00% | – |
Q4 2021 | $17,000 | -19.0% | 199 | -14.2% | 0.00% | – |
Q3 2021 | $21,000 | +61.5% | 232 | +74.4% | 0.00% | – |
Q2 2021 | $13,000 | -13.3% | 133 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | -11.8% | 133 | +7.3% | 0.00% | – |
Q4 2020 | $17,000 | -39.3% | 124 | -63.5% | 0.00% | – |
Q3 2020 | $28,000 | +100.0% | 340 | +4.3% | 0.00% | – |
Q2 2020 | $14,000 | 0.0% | 326 | 0.0% | 0.00% | – |
Q1 2020 | $14,000 | 0.0% | 326 | 0.0% | 0.00% | – |
Q4 2019 | $14,000 | -6.7% | 326 | -8.9% | 0.00% | – |
Q3 2019 | $15,000 | -34.8% | 358 | 0.0% | 0.00% | – |
Q2 2019 | $23,000 | -8.0% | 358 | 0.0% | 0.00% | – |
Q1 2019 | $25,000 | +127.3% | 358 | +37.7% | 0.00% | – |
Q4 2018 | $11,000 | -45.0% | 260 | 0.0% | 0.00% | – |
Q3 2018 | $20,000 | 0.0% | 260 | 0.0% | 0.00% | – |
Q2 2018 | $20,000 | +53.8% | 260 | 0.0% | 0.00% | – |
Q1 2018 | $13,000 | – | 260 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |